期刊
DRUG DISCOVERY TODAY
卷 23, 期 5, 页码 960-973出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2017.11.003
关键词
-
资金
- ICAR, New Delhi, India
- UGC, New Delhi, India
- Jaswant Singh Gill Pharma Research Fellowship
Galactosylated nanocarriers have recently emerged as viable and versatile tools to deliver drugs at an optimal rate specifically to their target tissues or cells, thus maximizing their therapeutic benefits while circumventing off target effects. The abundance of lectin receptors on cell surfaces makes the galactosylated carriers suitable for the targeted delivery of bioactives. Additionally, tethering of galactose (GAL) to various carriers, including micelles, liposomes, and nanoparticles (NPs), might also be appropriate for drug delivery. Here, we review recent advances in the development of galactosylated nanocarriers for active tumor targeting. We also provide a brief overview of the targeting mechanisms and cell receptor theory involved in the ligand-receptor-mediated delivery of drug carriers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据